Metronomic Dosing for Pancreatic Cancer Combination Therapy Treatment Association With Reduced Neutropenia

Metronomic dosing for pancreatic cancer combination therapy treatment association with reduced neutropenia. METHODS: This research aims to evaluate the use of combination therapy for shrinking tumor size in patients with metastatic pancreatic cancer using gemzar/paclitaxel combination therapy for tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Sharoon, Killian, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
MEETING PROCEEDINGS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906525/
http://dx.doi.org/10.1200/GO.22.22000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906525/
http://dx.doi.org/10.1200/GO.22.22000

Ejemplares similares